Syncope resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
Syncope is defined as a transient LOC, characterized by rapid onset, short duration and spontaneous complete recovery due to cerebral hypoperfusion.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Syncope in the Context of Transient LOC
Determine if there was LOC | |||||||||||||||||||||||||||||||||
If yes: ❑ Rapid onset? ❑ Short duration? ❑ Spontaneous complete recovery? | If no: | ||||||||||||||||||||||||||||||||
If no to ≥1; exclude the following before proceeding with syncope evaluation: ❑ Coma ❑ Aborted SCD ❑ Epilepsy -Perform neurological evaluation -Perform tilt testing, preferably with concurrent EEG and video monitoring if doubt of mimicking epilepsy ❑ Metabolic disorders: ♦ Hypoglycemia ♦ Hypoxia ♦ Hyperventilation with hypocapnia ❑ Intoxication ❑ Vertebrobasilar TIA | If yes: ❑ Transient LOC | ||||||||||||||||||||||||||||||||
Non traumatic | Traumatic | ||||||||||||||||||||||||||||||||
Suspect: | |||||||||||||||||||||||||||||||||
Diagnostic Flowchart in Patients with Suspected Syncope
❑ Initial Assessment: | |||||||||||||||||||||||||||||||||||||||||
Syncope | T-LOC non syncopal | ||||||||||||||||||||||||||||||||||||||||
Certain diagnosis | Uncertain etiology | ❑ Confirm with specific test: OR ❑ Consult with specialist | |||||||||||||||||||||||||||||||||||||||
Risk stratification High risk criteria: ❑ Severe structural or ©AD ❑ Important comorbidities: ❑ Clinical or ECG features suggesting arrhythmic syncope: -syncope during exertion or supine -palpitations at the time of syncope -family history of SCD -non- sustained VT -conduction abnormalities with QRS >120 ms -sinus bradycardia -pre-exited QRS complex -prolonged or short QR interval -brugada pattern -ARVC -Severe anemia -Electrolyte intolerance | |||||||||||||||||||||||||||||||||||||||||
If arrhythmic cause identified: (EPS) | High risk: ❑ Early Evaluation and treatment | Low risk, recurrent syncopes: ❑ Cardiac or neurally mediated tests as appropriate OR ❑ Delayed treatment guided by EKG documentation | Low risk, single or rare syncope: ❑ No further evaluation | ||||||||||||||||||||||||||||||||||||||
Specific etiology diagnostic evaluation | |||||||||||||||||||||||||||||||||||||||||
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]
Do's
- Tilt testing is indicated when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.
- Tilt testing should be considered to discriminate between reflex and OH syncope.
- Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy.
- If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose OH.
- Perform CSM if patient >40 years with syncope of unknown aetiology after initial evaluation.
- If multiple unexplained falls; perform tilt testing.
- Consider ILR before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
- Evaluate neurologically if syncope is due to ANF, to evaluate underlying disease.
Don'ts
- Don't performCSM in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis.
- Don't use tilt testing for assessment of treatment.
- Don't perform isoproterenol tilt testing in patients with ischaemic heart disease.
- Don't use ATP test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope,.
- Don't perform EPS if there is already indication for ICD in patients with ischemic heart with suspected arrhythmic cause.
- Don't perform EPS in patients with normal ECK, no heart disease, and no palpitations.
References
- ↑ Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter
|month=
ignored (help) - ↑ Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter
|month=
ignored (help) - ↑ Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422 Check
|pmid=
value (help).